Hysteromyoma is a bening tumor formed from myometrium. About 50-70% of surgical procedures are connected with hysteromyoma.
Most often this disease is caused by hormonal disorders in female organism. Apart from surgical treatment conservative therapy is indicated with application of gestagenic drugs with the aim of inhibiting growth of tumor (norcolut, dufastone, utrogestan) in cycles from the 16th to 25th days of menstrual cycle during 3-6 months annually, regular electrophoresis with potassium iodide in pubic region, in some cases women aged 40 and older are recommended to take androgenic agents (for example testosterone) which often cause side effects.
EnergoIod can be used along with traditional therapy:
- EnergoIod normalizes balance of reproductive and thyroid hormones being the main causes of hysteromyoma, decreases risk of hormone-dependent tumors in reproductive organs and mammary glands;
- EnergoIod is not a hormonal preparation;
- EnergoIod eliminates effectively pathological symptoms of myoma and prevents formation of malignant tumors in female reproductive system;
- Use of EnergoIod in hormonal and inflammatory diseases of female reproductive system allows to prevent formation of myoma;
EnergoIod preparations will help you to solve many problems!
Use of EnergoIod in this disease
Use of EnergoIod in this disease
Weight, kg
For disease
Lung disease
Average disease
Severe disease
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
40
2
4
4
8
6
12
50-60
3
6
6
12
9
18
70-80
4
8
8
16
12
24
90-100
5
10
10
20
15
30
110-120
6
12
12
24
17
34
Use of a concentrate
Shake before use. It requires dilution with cold or cool drinking water (in an amount of 100-200 ml).
The daily dose calculated for 1 kg body weight, depending on the severity and course of the disease is 0.1-0.3 ml / kg body weight / day, divided into 2 doses.
The drug is taken on an empty stomach in the morning and in the evening before going to bed for 30 days.
If necessary, a second course in 15 days.
The number of courses per year depending on the severity of the pathological process.
Carrying out an accelerated rate with the maximum dose for 15 days.